Get the Stockscreener App
50.97
0.20%
-0.10
Doximity Inc stock is traded at $50.97, with a volume of 1.28M.
It is down -0.20% in the last 24 hours and down -23.74% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
See More
Previous Close:
$51.07
Open:
$51
24h Volume:
1.28M
Relative Volume:
0.79
Market Cap:
$7.00B
Revenue:
$550.17M
Net Income/Loss:
$201.35M
P/E Ratio:
50.97
EPS:
1
Net Cash Flow:
$232.07M
1W Performance:
+6.19%
1M Performance:
-23.74%
6M Performance:
-0.10%
1Y Performance:
-4.80%
1-Day Range:
$50.88
$51.64
1-Week Range:
$46.04
$51.64
52-Week Range:
$46.04
$85.21
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
50.97 | 9.62B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
240.67 | 39.44B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
77.21 | 13.67B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
104.99 | 9.08B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.04 | 7.07B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-25 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-10-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-25 | Downgrade | Goldman | Neutral → Sell |
| Jul-09-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jun-02-25 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-07-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-07-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
How Do Investors Really Feel About Doximity Inc? - Benzinga
SG Americas Securities LLC Lowers Stake in Doximity, Inc. $DOCS - MarketBeat
Medical AI Co. Accused Of 'Smear Campaign' Against Rivals - Law360
Universal Beteiligungs und Servicegesellschaft mbH Trims Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Position Trimmed by Sierra Summit Advisors LLC - MarketBeat
Nomura Asset Management Co. Ltd. Acquires Shares of 7,202 Doximity, Inc. $DOCS - MarketBeat
Nemes Rush Group LLC Invests $1.11 Million in Doximity, Inc. $DOCS - MarketBeat
Franklin Resources Inc. Acquires 1,108,162 Shares of Doximity, Inc. $DOCS - MarketBeat
Prudential PLC Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Robust Financial Progress and Strategic Adjustments - StocksToTrade
Doximity Stock Surges Amid Strong Earnings and Strategic Outlook - StocksToTrade
Doximity (DOCS) Shines with Strong Q2 Results, Revenue Projections - timothysykes.com
Neo Ivy Capital Management Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Shares Bought by Handelsbanken Fonder AB - MarketBeat
Ensign Peak Advisors Inc Has $42.67 Million Position in Doximity, Inc. $DOCS - MarketBeat
Should Raymond James’ AI-Focused Upgrade Require Action From Doximity (DOCS) Investors? - Yahoo Finance
Doximity Projects Strong Q3 Revenue Guidance Amid Healthcare Shifts - StocksToTrade
Doximity Surges with Strong Q2 Results and Strategic Roadmap - StocksToTrade
Is Doximity’s Recent 24% Pullback a Chance or a Caution for Investors in 2025? - Yahoo Finance
Doximity Stock Climbs: Strong Financial Performance and Analyst Upgrades - timothysykes.com
Doximity’s Revenue Surge and Upbeat Forecasts Propel Stock Forward - timothysykes.com
Why Is Doximity (DOCS) Stock Soaring Today - The Globe and Mail
Doximity’s Unexpected Surge: Analyzing the Latest Performance - StocksToTrade
Doximity rises after Raymond James upgrades to 'strong buy' - TradingView
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
Raymond James bullish on Doximity saying long term growth trumps seasonal noise - Investing.com Canada
Hims & Hers Accelerates Its Clinician-Led, Platform-Driven Care Model - sharewise.com
EFG Asset Management Americas Corp. Acquires Shares of 26,601 Doximity, Inc. $DOCS - MarketBeat
Raymond James upgrades Doximity stock rating to Strong Buy on compelling valuation - Investing.com
Doximity, Inc. $DOCS Shares Sold by Empowered Funds LLC - MarketBeat
Doximity, SentinelOne, Asure Software, Workday, and Bandwidth Shares Are Falling, What You Need To Know - Finviz
Doximity: Strong Growth but What's Next? - AOL.com
Is Doximity Inc. stock a top pick in earnings seasonJuly 2025 Closing Moves & Weekly High Return Forecasts - newser.com
Can Doximity’s (DOCS) Share Buybacks and Earnings Strength Tell Us More About Its Growth Vision? - simplywall.st
Will Doximity Inc. Class stock outperform benchmarks2025 Market Overview & Expert Curated Trade Ideas - newser.com
Will Doximity Inc. Class stock maintain strong growthQuarterly Performance Summary & Weekly Breakout Stock Alerts - newser.com
How risky is Doximity Inc. Class stock compared to peersJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - newser.com
Will Doximity Inc. Class stock benefit from mergers2025 Price Targets & Weekly High Return Stock Opportunities - newser.com
Why Doximity Inc. Class stock could outperform next yearEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Real time social sentiment graph for Doximity Inc.Market Volume Report & Verified Trade Idea Suggestions - newser.com
Is Doximity Inc. stock overvalued by current metricsTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Doximity Inc. stock recover faster than market2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Stocks to Buy & Sell: Volatility Analysis for Doximity, Marriott, International PaperNews and Statistics - IndexBox
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):